US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Aptose Biosciences Inc (APTO)
Aptose Biosciences Inc (APTO) ニュース

APTO

Aptose Biosciences (APTO)

Aptose Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:APTO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/11	00 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/05/07	05 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2024/03/02	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/15	06 : 51	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	08 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	07 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	07 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	07 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	07 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	06 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	06 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	06 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	06 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/08	06 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APTO	Aptose Biosciences Inc
2024/02/01	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2024/01/27	07 : 30	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:APTO	Aptose Biosciences Inc
2024/01/26	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2024/01/26	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:APTO	Aptose Biosciences Inc
2024/01/26	11 : 44	Edgar (US Regulatory)	Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]	NASDAQ:APTO	Aptose Biosciences Inc
2024/01/20	11 : 50	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:APTO	Aptose Biosciences Inc
2023/12/30	06 : 10	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:APTO	Aptose Biosciences Inc
2023/12/11	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2023/12/11	20 : 15	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:APTO	Aptose Biosciences Inc
2023/12/01	07 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2023/11/10	07 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:APTO	Aptose Biosciences Inc
2023/11/02	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2023/10/30	22 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2023/10/26	23 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc
2023/10/23	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APTO	Aptose Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:APTO

1 2 3 4 5 6 7 8 9 10 次へ >>

Health Care Select Sector

American Express

Deutsche Telekom (QX)

BNP Paribas (QX)

Financial Select Sector

Verizon Communications

US Dollar vs Sterling

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約